Research

Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.

There are thousands of whole genome sequences in St. Jude Cloud. And you can use them.

Carole Weaver Clements, PhD

Because of St. Jude Cloud, terabytes of pediatric cancer genomic data can now be readily accessed, analyzed and visualized.

Biostatistical model resolves questions on antibiotic side effects

Safety in numbers: Advanced biostatistical model resolves questions on vancomycin side effects

Josh Wolf, PhD, MBBS

Dr. Josh Wolf explains how biostatistics resolved safety questions on preemptive vancomycin for acute myeloid leukemia patients after chemotherapy.

A vaccine to prevent cancer? It’s already here.

Ellis J. Neufeld, MD, PhD

Many adolescents fail to get a key vaccination that can prevent cancer. Learn what doctors know about the HPV cancer vaccine.

Five ways to take confirmation bias out of your experimental results

Charles Rock, PhD

The most important part of research is that you must not fool yourself — and you’re the easiest person to fool.

Heme synthesis linked with acute myeloid leukemia

Blood's oxygen transporter revealed as power source for aggressive pediatric cancer

John Schuetz, PhD

Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.

ASH 2017: Preliminary results show gene therapy gains in X-linked SCID

ASH 2017: Preliminary results show gene therapy gains in SCID

Ewelina Mamcarz, MD

Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.

ASH 2017: The role of GATA3 in Ph-like acute lymphoblastic leukemia

ASH 2017: GATA3 in Ph-like acute lymphoblastic leukemia

Jun Yang, PhD

Jun J. Yang, PhD, shares research presented at ASH that highlights the role the GATA3 oncogene plays in a high-risk subset of acute lymphoblastic leukemia.

ASH17: Research on TP53 gene variations presented at first ALL session

ASH 2017: Research on TP53 gene variations featured in first ALL session

Jun Yang, PhD

Jun J. Yang, PhD, offers highlights of the first ALL session at the American Society of Hematology (ASH) meeting, including his work on TP53. Read more.